Subspecialties Hematology, Profession, Laboratory management

Hematology: Challenges and Opportunities

What does the future hold for the field of hematology?

Michael Schubert | 03/27/2020 | Quick Read

Email*

Choose a password

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the Infectious Diseases field I want to stay up to date with the Pathologist Educator field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Subspecialties Hematology, Profession, Laboratory management

The Royal College of Pathologists (2020). Available at: bit.ly/2I5in2Q.

Michael Schubert

While obtaining degrees in biology from the University of Alberta and biochemistry from Penn State College of Medicine, I worked as a freelance science and medical writer. I was able to hone my skills in research, presentation and scientific writing by assembling grants and journal articles, speaking at international conferences, and consulting on topics ranging from medical education to comic book science. As much as I’ve enjoyed designing new bacteria and plausible superheroes, though, I’m more pleased than ever to be at Texere, using my writing and editing skills to create great content for a professional audience.

ClearLLab 10C Panel Markers and how they are combined

05/05/2020 | Contributed by Beckman Coulter Life Sciences

ClearLLab Control Cells - A Process Control for ClearLLab 10C Application

05/05/2020 | Contributed by Beckman Coulter Life Sciences

The Analysis of FFPE Samples by Next-Generation Sequencing (NGS) of Key Genes for Research into Breast and Ovarian Cancer

05/08/2019 | Contributed by Oxford Gene Technology

Subspecialties Oncology

Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer

05/31/2022 | Sponsored by Ultivue

Subspecialties Oncology

Two Perspectives: Patient and Hematopathologist Discussion on Importance of CML Monitoring

05/24/2022 | Sponsored by Cepheid

Subspecialties Oncology

Optimizing Comprehensive Genomic Profiling and NTRK Fusion Detection in Advanced Cancers

12/01/2021 | Sponsored by Illumina

Subspecialties Microbiology and immunology

Pathology’s Role in Fighting Antimicrobial Resistance

08/08/2022 | Liv Gaskill

Diagnostics Liquid biopsy

Liquid Biopsies: Reach for the Stars

08/11/2022 | Dan Norton | 3 min read

Diagnostics Biochemistry and molecular biology

Future Trends in Spatial Biology

08/10/2022 | Tian Yu | 8 min read

Outside the Lab Profession

Pathology in Challenging Times

08/03/2022 | Gilbert Nkya | 3 min read

Diagnostics COVID-19

Solving the Challenge of COVID-19

08/01/2022 | Wei Juan Wong | 3 min read